Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NKp46 is a type I transmembrane glycoprotein expressed almost exclusively on natural killer (NK) cells. It functions as a key activating receptor, triggering cytolytic activity and cytokine production upon engagement with pathogen-derived or stress-induced ligands on target cell surfaces. It plays roles in anti-tumor immunity and antiviral responses but may also contribute to autoimmune conditions.
Engagement with ligands or cross-linking by antibodies induces rapid increases in intracellular calcium, triggers cytolytic activity, and stimulates cytokine/lymphokine production.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Natural Killer Cell p46-Related Protein (NKp46).